The latter comprise a large number of mutations, the most common being EGFR exon 20 insertions, which represent up to 2.5% of all lung adenocarcinomas and 6% of EGFR-mutant NSCLC cases [29]. This evidence concerns the gene EGFR and lung adenocarcinoma.